title: Immunological therapy in urological malignancy: novel combination strategies.
abstract: At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies.
authors.affiliation: Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90024, USA. dfinley@mednet.ucla.edu
authors.forename: David S
authors.initials: DS
authors.lastname: Finley
authors.forename: Frederic
authors.initials: F
authors.lastname: Pouliot
authors.forename: Arnold I
authors.initials: AI
authors.lastname: Chin
authors.forename: Brian
authors.initials: B
authors.lastname: Shuch
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Pantuck
authors.forename: Arie S
authors.initials: AS
authors.lastname: Belldegrun
authors.forename: Jean B
authors.initials: JB
authors.lastname: Dekernion
mesh_terms: D019496:Cancer Vaccines; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000628:therapy*
chemical_list: D019496:Cancer Vaccines